top of page
GT Logo White.png

2026
AbbVie US + EU
Golden Ticket

Applications are closed.

AbbVie_logo.svg.png
biolabslogo.png

AbbVie is launching a US and Europe based golden ticket. The award consists of one golden ticket, which provides one year of fully paid individual bench, a desk and membership at one of BioLabs’ operating locations in the US, France or Germany.  The award is intended for early-stage biotech companies working on research and development in the Field of immunology, neurosciences, oncology, aesthetics, and obesity.​ Additional eligibility requirements are listed below.​

​

Application

Application Process

The official application process can be found below. Please read and verify your availability before submitting your application. 

calendar.png

Application

Complete the application form and upload a non-confidential pitch deck for this competition.

​

printer.png

Terms & Conditions

Each applicant must acknowledges that they have read the official Terms and Conditions and they fully agrees and accept them. 

lightbulb.png
Benefits

Golden Ticket Benefits

BioLabs035.jpg

1-year membership, lab bench and office space

to de-risk your technology and scale your business 

TechFW

A buzzing community

of entrepreneurs

connecting startups to local orgs and investors

BioLabs_Thermo_PR_Collaboration.png

A no strings

attached model

to maintain complete ownership of your IP

christina-wocintechchat-com-DcHbAegafZg-unsplash.jpg

Mentoring and support from AbbVie's

drug discovery and development experts 

MicrosoftTeams-image4072ff6cdfbe3f3b659bf511b8cddfd93d42c64b15b1c4048053eed0e94325b7.png

Gateway to a

potential collaboration

with AbbVie, a leading pharma partner 

Application requirements  

AbbVie is looking for biotech companies that fit the following criteria:​

  • Have primary business location in US, France or Germany

  • Be an early stage-startup focused on developing novel therapeutic approaches for immunology,neurosciences, oncology, aesthetics, and obesity​

  • More detailed information about these research areas can be found here

  • Excluded are devices, diagnostics and similar technologies.

  • For additional requirements refer to the Terms and Conditions document.

Eligibility
The Application Process

The Application Process

01

Submit applications by
April 30, 2026

02

A subset of applications will be identified as finalist by the contest judges by
May 08, 2026

03

Finalists will present their company & scientific concept at a virtual event 
on May (Date TBC)

04

One Golden Ticket will be awarded to one winner

Judging criteria

Contact Us

If you have any questions about this Golden Ticket,

contact: global_goldenticket@abbvie.com 

​

For any questions about BioLabs,

contact: goldenticket@biolabs.io

20220224_gzs_hd_02_visualisierung_biolabs_aussen_edited_edited_edited_edited_edited.png
bottom of page